Lupus is an autoimmune disease where the body’s immune system attacks its own tissues and organs, causing inflammation and damaging organs. A new ...

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.

The Lupus Spiel is a pro-am curling tournament that raises awareness and money for lupus research. The results are in for ...

Living with lupus can be overwhelming, says columnist Candace Semien, but it's important to hold tight and fight for yourself ...

New research reveals disturbing nightmares and hallucinations may serve as early warning signs of lupus, potentially helping patients receive treatment sooner.

Despite advancements in the management of systemic lupus erythematosus (SLE), patients experience poor health-related quality of life (hrQoL) and premature death due to disease severity and treatment ...

Up to 74% of people with lupus also have high blood pressure. To lower your likelihood of cardiovascular issues and other problems, it’s important to treat your high blood pressure. There are ...

Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related conditions that ...

But today, most people with lupus have a typical life expectancy with treatment. Frequency of flares and complications may influence your outlook with lupus. The Lupus Foundation of America ...

Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...

May 23, 2024 — Treatment of autoimmune diseases like lupus has long relied on steroids to knock down the immune system, but more targeted therapies are currently undergoing clinical trials.

The most common side effects of Lunsumio include: tiredness, rash ... innovative new treatment options to people living with kidney and kidney-related diseases, including lupus nephritis ...